NDT Pharmaceuticals Inc.

NDT Pharmaceuticals Inc.

OOTC:NDTP
0.16
USD
+0.05
(+46.48%)
-29.58EPS

Share Statistics

As of June 30, 2008, NDT Pharmaceuticals Inc. has 42,350.00 shares outstanding.

Shares Outstanding42,350.00

Financial Position

As of June 30, 2008, NDT Pharmaceuticals Inc. maintains a current ratio of - -, meaning it holds the short-term assets needed to cover near-term liabilities.

Debt / Equity-89.93
Debt / EBITDA-0.14

Financial Efficiency

These figures cover the twelve months ended June 30, 2008. Return on assets (ROA) is negative at -55,756.14, reflecting losses generated across the asset base.

Return on Assets (ROA)-55,756.14

Stock Price Statistics

USD

As of the close on November 16, 2026, NDT Pharmaceuticals Inc.'s stock has declined approximately 89.24% over the past 52 weeks. The 50-day moving average sits at 0.32, while the 200-day moving average is 0.77.

52-Week Price Change-89.24%
50-Day Moving Average0.32
200-Day Moving Average0.77

Income Statement

USD

These figures cover the twelve months ended June 30, 2008. EBITDA reached -1.09M, while operating income came in at -93,469.00.

Operating Income-93,469.00
Net Income-1.23M
EBITDA-1.09M
EBIT-1.09M
Earnings Per Share (EPS)-29.58

Balance Sheet

USD

As of June 30, 2008, NDT Pharmaceuticals Inc. holds - - in cash and equivalents against 158,284.00 in total debt, resulting in a net debt position of 158,284.00. Total book value stands at -176,005.00, with working capital of -176,005.00 providing operational flexibility.

Total Debt158,284.00
Net Debt158,284.00
Equity (Book Value)-176,005.00
Book Value Per Share-4.16
Working Capital-176,005.00

Cash Flow

USD

NDT Pharmaceuticals Inc. produced -83,796.00 in operating cash flow over the twelve months ended June 30, 2008.

Operating Cash Flow-83,796.00
Free Cash Flow-83,796.00
FCF Per Share-2.02

Stock Splits

NDT Pharmaceuticals Inc.'s most recent stock split took place on May 29, 2020 with a 1000:1 split ratio.

Last Split Date5/29/2020
Split Ratio1000:1